---
schema_version: "secwatch.filing_event.v1"
accession: "0001437402-25-000008"
form_type: "8-K"
ticker: "ARDX"
cik: "0001437402"
company_name: "ARDELYX, INC."
filed_at: "2025-10-14T23:59:59+00:00"
generated_at: "2026-05-17T03:52:14.065039+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Ardelyx appoints Sue Hohenleitner as CFO

## Summary
- Appointed Sue Hohenleitner as CFO effective Nov 4, 2025; she joins Oct 13, 2025.
- Hohenleitner previously VP & CFO of J&J Innovative Medicine NA ($36B business).
- Annual base salary $550,000, target bonus 45% of base, sign-on bonus $180,000.
- Received option to purchase 578,104 shares at $5.01/share and 146,896 RSUs, four-year vesting.

## SEC filing metadata
- accession: 0001437402-25-000008
- form_type: 8-K
- ticker: ARDX
- cik: 0001437402
- company_name: ARDELYX, INC.
- filed_at: 2025-10-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1437402/000143740225000008/0001437402-25-000008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1437402/000143740225000008/ardx-20251013.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437402-25-000008
- JSON: https://secwatch.observer/filing/0001437402-25-000008.json
- Plain text: https://secwatch.observer/filing/0001437402-25-000008.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.